XML 53 R42.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Weighted Average Assumptions used to Estimate Fair Value of Options Granted

The fair value of each option granted during the periods was estimated on the date of grant using the following weighted average assumptions:

 

 

2024

 

 

2023

 

 

2022

 

Expected volatility

 

 

86

%

 

 

72

%

 

 

68

%

Expected term in years

 

 

6

 

 

 

6

 

 

 

6

 

Risk-free interest rate

 

 

3.8

%

 

 

3.3

%

 

 

1.8

%

Dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

Schedule of Stock Option Activity

A summary of option activity for 2024 is presented below:

 

 

Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2023

 

 

2,141,360

 

 

$

65.00

 

 

 

 

 

 

 

Granted

 

 

3,334,887

 

 

 

6.91

 

 

 

 

 

 

 

Exercised

 

 

(16,668

)

 

 

12.26

 

 

 

 

 

 

 

Forfeited

 

 

(93,758

)

 

 

26.87

 

 

 

 

 

 

 

Expired

 

 

(122,905

)

 

 

63.56

 

 

 

 

 

 

 

Outstanding at December 31, 2024

 

 

5,242,916

 

 

 

28.76

 

 

 

8.06

 

 

$

 

Vested or expected to vest at December 31, 2024

 

 

5,242,916

 

 

 

28.76

 

 

 

8.06

 

 

$

 

Exercisable at December 31, 2024

 

 

2,534,682

 

 

$

50.07

 

 

 

6.52

 

 

$

 

Summary of Non-vested Stock Activity

A summary of non-vested stock activity for 2024 is presented below:

 

 

Nonvested
Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Outstanding at December 31, 2023

 

 

27,163

 

 

$

37.20

 

Granted

 

 

48,561

 

 

 

11.96

 

Vested

 

 

(17,002

)

 

 

29.11

 

Forfeited

 

 

(16,500

)

 

 

21.82

 

Outstanding at December 31, 2024

 

 

42,222

 

 

$

17.30

 

Schedule of Share-Based Compensation Expense

The impact on our results of operations from share-based compensation for the years ended December 31, 2024, 2023, and 2022, was as follows (in thousands).

 

 

Year Ended

 

 

 

2024

 

 

2023

 

 

2022

 

Research and development

 

$

11,998

 

 

$

6,237

 

 

$

4,847

 

General and administrative

 

 

15,329

 

 

 

16,114

 

 

 

13,391

 

Total share-based compensation expense

 

$

27,327

 

 

$

22,351

 

 

$

18,238